Figure 3.
Effects of a 60-min infusion of a selective ETA receptor antagonist (BQ123) on transcutaneous oxygen tension (TcPO2) and toe blood pressure (TBP) in six patients with type 2 diabetes and critical limb ischemia.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.